(Q46161370)

20 December 2017

title

Follicular oestradiol and VEGF after GnRH antagonists or GnRH agonists in women with PCOS. (English)

1 reference

20 December 2017

author name string

Eda Vrtacnik-Bokal

series ordinal

1

1 reference

20 December 2017

Irma Virant Klun

series ordinal

2

1 reference

20 December 2017

Ivan Verdenik

series ordinal

3

1 reference

20 December 2017

publication date

1 January 2009

1 reference

20 December 2017

Reproductive BioMedicine Online

published in

1 reference

20 December 2017

volume

18

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

page(s)

21-28

1 reference

20 December 2017

Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

Gonadotropin-releasing hormone antagonists do not influence the secretion of steroid hormones but affect the secretion of vascular endothelial growth factor from human granulosa luteinized cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

Vascular endothelial growth factor and inhibin A in follicular fluid of infertile patients who underwent in vitro fertilization with a gonadotropin-releasing hormone antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

The treatment of patients with polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: a comparison of results with those of patients with tubal infertility.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

Vascular endothelial growth factor: basic science and clinical progress

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

Gonadotropin-releasing hormone antagonists increase follicular fluid insulin-like growth factor-I and vascular endothelial growth factor during ovarian stimulation cycles

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

Gonadotrophin regimens and oocyte quality in women with polycystic ovaries

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

Polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

Role of vascular endothelial growth factor in ovarian physiology and pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

Relationship of follicular fluid prorenin to oocyte maturation, steroid levels, and outcome of in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

Reproductive outcome of polycystic ovarian syndrome patients treated with GnRH antagonists and recombinant FSH for IVF/ICSI.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

Initiation of GnRH antagonist on Day 1 of stimulation as compared to the long agonist protocol in PCOS patients. A randomized controlled trial: effect on hormonal levels and follicular development

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

[Oocyte and embryo quality in polycystic ovary syndrome]

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

Relationship of ovarian stimulation response with vascular endothelial growth factor and degree of granulosa cell apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

Angiogenesis in developing follicle and corpus luteum.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

GnRH agonists vs antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

Assisted reproduction in the treatment of polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

Oocyte assessment and biological performance

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

Prolonged HCG action affects angiogenic substances and improves follicular maturation, oocyte quality and fertilization competence in patients with polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

Actions of gonadotropin-releasing hormone antagonists on steroidogenesis in human granulosa lutein cells

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960420-8

7 January 2021

10.1016/S1472-6483(10)60420-8

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017